Tradestie Institutional Equity Comparison Engine

IBD vs WWJD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

WWJD Overall Edge

WWJD Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Inspire International ETF (WWJD) driven by superior Momentum & Technical. Fundamentally, IBD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus WWJD at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, IBD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against WWJD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
IBD N/M vs WWJD N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner WWJD
1Y -4.4% vs +9.0% ยท 52W Pos 26% vs 47%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
IBD NYSE Arca
Inspire Corporate Bond ETF
Institutional Equity
$23.10
-0.04% 1D
Market Cap N/A
1M Return -0.56%
1Y Return -4.39%
Forward P/E N/M
Unified AI Score
44.1 / 100 HOLD
Tech 49.0 Fund 51.0 Flow 50.0 Mom 54.0
WWJD NYSE Arca
Inspire International ETF
Institutional Equity
$39.07
-1.58% 1D
Market Cap N/A
1M Return -0.02%
1Y Return +9.02%
Forward P/E N/M
Unified AI Score
51.0 / 100 HOLD
Tech 48.0 Fund 47.0 Flow 50.0 Mom 41.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IBD -4.39% WWJD +9.02% Spread: +13.41 pp (WWJD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IBD TTM Op. Margin: N/A WWJD TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IBD vs WWJD. Trailing 12-month operating profitability (IBD N/A vs WWJD N/A) and valuation multiples (IBD N/M vs WWJD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IBD (1) vs WWJD (2)
Institutional Metric IBD WWJD Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 26% ($22โ€“$25) 47% ($35โ€“$44) Stronger Trend WWJD
Beta / 30D Volatility Risk Regime 0.11ฮฒ ยท 5% Vol 0.79ฮฒ ยท 15% Vol Lower Realized Risk IBD
Unified Institutional Score Composite Signal 44.1 / 100 (HOLD) 51.0 / 100 (HOLD) Higher Composite WWJD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IBD vs WWJD Buy Guide
IBD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IBD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
WWJD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live WWJD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IBD nor WWJD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.